Inflammation and cancer

Recent data have expanded the concept that inflammation is a critical component of tumour progression. Many cancers arise from sites of infection, chronic irritation and inflammation. It is now becoming clear that the tumour microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration. In addition, tumour cells have co-opted some of the signalling molecules of the innate immune system, such as selectins, chemokines and their receptors for invasion, migration and metastasis. These insights are fostering new anti-inflammatory therapeutic approaches to cancer development.

[1]  P. Rous,et al.  CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES , 1941, The Journal of experimental medicine.

[2]  P. Rous,et al.  THE EXPERIMENTAL DISCLOSURE OF LATENT NEOPLASTIC CHANGES IN TARRED SKIN , 1941, The Journal of experimental medicine.

[3]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[4]  A. Richmond,et al.  Purification of melanoma growth stimulatory activity , 1986, Journal of cellular physiology.

[5]  J. Svobodova,et al.  Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. , 1986, Neoplasma.

[6]  R. Derynck,et al.  Effects of MGSA/GRO alpha on melanocyte transformation. , 1991, Oncogene.

[7]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[8]  A. Mantovani,et al.  Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells , 1992, The Journal of experimental medicine.

[9]  M. Bissell,et al.  Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. , 1994, Cancer research.

[10]  J. Rubin,et al.  Regulation of keratinocyte growth factor gene expression by interleukin 1. , 1994, The Journal of biological chemistry.

[11]  F. Beuvon,et al.  Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. , 1994, Journal of the National Cancer Institute.

[12]  L. DiPietro,et al.  WOUND HEALING: THE ROLE OF THE MACROPHAGE AND OTHER IMMUNE CELLS , 1995, Shock.

[13]  M. Blaser,et al.  Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. , 1995, Cancer research.

[14]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[15]  S. Kunkel,et al.  In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. , 1995, Journal of immunology.

[16]  L. Lund,et al.  Neutrophils Express Tumor Necrosis Factor-α During Mouse Skin Wound Healing , 1995 .

[17]  L. Lund,et al.  Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing. , 1995, The Journal of investigative dermatology.

[18]  J. Norgauer,et al.  Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. , 1996, Journal of immunology.

[19]  L. Lund,et al.  Impaired wound healing in mice with a disrupted plasminogen gene , 1996, Nature Medicine.

[20]  W. Wiktor-Jedrzejczak,et al.  Impaired tumor growth in colony‐stimulating factor 1 (CSF‐1)‐deficient, macrophage‐deficient op/op mouse: Evidence for a role of CSF‐1‐dependent macrophages in formation of tumor stroma , 1996, International journal of cancer.

[21]  S. Werner,et al.  Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. , 1996, Cytokine.

[22]  M. Burdick,et al.  Enhanced tumor‐forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth‐regulated cytokine β and γ proteins , 1997 .

[23]  S. Ryan,et al.  Retinal pigment epithelium cells promote the maturation of monocytes to macrophages in vitro. , 1997, Ophthalmic research.

[24]  R. Strieter,et al.  Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. , 1997, International journal of cancer.

[25]  M. Kedinger,et al.  Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine. , 1997, Gastroenterology.

[26]  C. Paraskeva,et al.  Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  I. Mellman,et al.  Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures , 1998, European journal of immunology.

[28]  P. Welker,et al.  Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. , 1998, Molecular biology of the cell.

[29]  H. Maeda,et al.  Nitric oxide and oxygen radicals in infection, inflammation, and cancer. , 1998, Biochemistry. Biokhimiia.

[30]  M. Iannettoni,et al.  Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. , 1998, The Journal of clinical investigation.

[31]  H. Kleinman,et al.  Tumor-associated macrophages as targets for cancer therapy. , 1998, Journal of the National Cancer Institute.

[32]  A. Varki,et al.  P-selectin deficiency attenuates tumor growth and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Hanahan,et al.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.

[34]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[35]  M. Kuwano,et al.  Biological implications of macrophage infiltration in human tumor angiogenesis , 1999, Cancer Chemotherapy and Pharmacology.

[36]  H. Friess,et al.  Detection and localization of MIP‐3α/LARC/exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer , 1999 .

[37]  F M Watt,et al.  The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. , 1999, Development.

[38]  G. Hannon,et al.  A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.

[39]  S. Yuspa.  Overview of carcinogenesis: past, present and future. , 2000, Carcinogenesis.

[40]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[41]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[42]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[43]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[44]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[45]  H. Adami,et al.  Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.

[46]  B. Gold,et al.  The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. , 2000, Annual review of microbiology.

[47]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[48]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[49]  P. Allavena,et al.  The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues , 2000, Immunological reviews.

[50]  J. Baron,et al.  Nonsteroidal anti-inflammatory drugs and cancer prevention. , 2000, Annual review of medicine.

[51]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[52]  M. Moore,et al.  The role of chemoattraction in cancer metastases. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[53]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[54]  David R. Nadeau,et al.  Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Musiani,et al.  The intriguing role of polymorphonuclear neutrophils in antitumor reactions. , 2001, Blood.

[56]  P. Allavena,et al.  Macrophage control of inflammation: negative pathways of regulation of inflammatory cytokines. , 2001, Novartis Foundation symposium.

[57]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[58]  I. Weissman,et al.  L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Clayman,et al.  Chemokines in cancer , 2001, Expert Reviews in Molecular Medicine.

[60]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[61]  A. Zlotnik,et al.  Chemokines: agents for the immunotherapy of cancer? , 2002, Nature Reviews Immunology.

[62]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[63]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[64]  C. Ohyama,et al.  Sialyl Lewis X-dependent lung colonization of B16 melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin. , 2002, Cancer research.

[65]  C. Heldin,et al.  Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. , 2002, Immunology letters.

[66]  K. Alitalo,et al.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.

[67]  G. Dranoff.  Immune recognition and tumor protection , 2002 .

[68]  Takeshi Tokuhisa,et al.  Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation , 2002, The Journal of experimental medicine.

[69]  J. Norton,et al.  Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. , 2002, Cancer research.

[70]  Drew M. Pardoll,et al.  Vaccines: Spinning molecular immunology into successful immunotherapy , 2002, Nature Reviews Immunology.

[71]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[72]  F. Balkwill.  Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.

[73]  B. Evers,et al.  Inflammation and the development of pancreatic cancer. , 2002, Surgical oncology.

[74]  Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. , 2002, Clinical immunology.

[75]  B. Jenkins,et al.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice , 2002, Nature Medicine.

[76]  K. O'Byrne,et al.  Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. , 2002, Advances in cancer research.

[77]  D. Green,et al.  Regional analysis of p53 mutations in rheumatoid arthritis synovium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[79]  Ajit Varki,et al.  Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Jonathan Braun,et al.  Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. , 2002, Gastroenterology.

[81]  E. Clair,et al.  Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease , 2002 .

[82]  Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation , 2003 .

[83]  J. Segall,et al.  Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.

[84]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[85]  A. Chakrabarty,et al.  Microorganisms and Cancer: Quest for a Therapy , 2003, Journal of bacteriology.

[86]  C. Brigati,et al.  Tumors and inflammatory infiltrates: Friends or foes? , 2004, Clinical & Experimental Metastasis.